Iceland· IS-EU/1/26/2028/001-002
mCOMBRIAX
A medicinal product, registered in Iceland by MODERNA BIOTECH SPAIN, S.L..
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
The record
At a glance
Icelandic Medicines Agency (Iceland)- Manufacturer
- MODERNA BIOTECH SPAIN, S.L.
- Country
- Iceland (IS)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fd158c43-68eb-45d7-add7-3aa623ac0356 GET /v1/drugs/fd158c43-68eb-45d7-add7-3aa623ac0356?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Stungulyf, ördreifa í áfylltri sprautu",
"source": "lyfjastofnun",
"atc_raw": "15",
"marketed": false,
"strength": null,
"ma_number": "EU/1/26/2028/001-002",
"substance": "mRNA encoding Influenza A, H1N1 strain, hemagglutinin glycoprotein,mRNA encoding Influenza A, H3N2 strain, hemagglutinin glycoprotein,mRNA encoding Influenza B/Victoria, hemagglutinin glycoprotein,mRNA encoding SARS-CoV 2, variant XBB.1.5, spike glycoprotein, N-terminal domain and receptor-binding domain",
"other_info": null,
"legal_status": null,
"ma_issued_serial": "46132"
}See everything about mCOMBRIAX.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.